BioSpace News Archive

Genprex, Inc. today announced that the China National Intellectual Property Administration has granted Genprex China Patent No: 201780076886.X.

GRI Bio, Inc. today announced that Marc Hertz, Ph.D. , President and Chief Executive Officer, Albert Agro, Ph.D., Chief Medical Officer and Vipin Kumar, Ph.D., Chief Scientific Officer of GRI Bio will participate in the Virtual Investor Summer Spotlight Series on Tuesday, July 11, 2023 at 2:00 PM ET.

Aeterna Zentaris Inc. today announced that Dr. Klaus Paulini, Chief Executive Officer and Eckhard Guenther, PhD, Managing Director and SVP, Business Development of Aeterna Zentaris, will participate in the Virtual Investor Summer Spotlight Series on Wednesday, July 13, 2023, at 10:00 AM ET.

Sorrento Therapeutics, Inc. (OTC: SRNEQ) today announced positive results from a China phase IIa study of Abivertinib on R/R MZL and its plan for a pivotal study.

Evolution Optiks Limited announced today that Prof. Dr. Thomas Neuhann had joined the ranks of experts serving on the Advisory Board of the company.

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, is set to unveil its “PURE Genius” food safety program at the 2023 International Association for Food Protection (IAFP) show in Toronto, Ontario, Canada on July 16th -19th, 2023.

Liberate Medical, an emerging leader in the development of novel non-invasive neurostimulation devices focused on transforming respiratory care, announced today the successful closure of its $6.2M Series B financing round.

Simufilam Slowed Cognitive Decline by 38% Versus Placebo Over 6 months in Patients with Mild-to-Moderate Alzheimer’s Disease.

Clarius Mobile Health, a leading provider of high-definition handheld ultrasound systems, and Usono, a developer of innovative ultrasound accessories, joined forces today at the ECSS Paris 2023 congress to introduce a ground-breaking wireless and wearable ultrasound imaging solution for researchers studying the anatomy of people while they move.

Biosion, Inc. (“Biosion”), a global, clinical-stage biotechnology company, today announced the appointment of Furqan Ahmed, PharmD., as the Vice President and Head of Business Development.